Human pluripotent stem cell-derived cardiomyocytes represent a promising cell source for cardiac repair. However, their clinical translation is hindered by limited evidence for functional benefits in primate models, potential risks for arrhythmias, and teratoma formation. A recent study by Liu et al. (2018) makes significant progress on these critical issues. Human pluripotent stem cell-derived cardiomyocytes represent a promising cell source for cardiac repair. However, their clinical translation is hindered by limited evidence for functional benefits in primate models, potential risks for arrhythmias, and teratoma formation. A recent study by Liu et al. (2018) makes significant progress on these critical issues.
CITATION STYLE
Tu, C., & Zoldan, J. (2018, September 6). Moving iPSC-Derived Cardiomyocytes Forward to Treat Myocardial Infarction. Cell Stem Cell. Cell Press. https://doi.org/10.1016/j.stem.2018.08.011
Mendeley helps you to discover research relevant for your work.